Janux Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $394k | 8.7k | 45.43 |
| 2024-06-30 | $377k | 9.0k | 41.89 |
| 2024-03-31 | $230k | 6.1k | 37.65 |
| 2023-12-31 | $57k | 5.3k | 10.73 |
| 2023-09-30 | $43k | 4.3k | 10.08 |
| 2023-06-30 | $79k | 6.6k | 11.87 |
| 2022-09-30 | $999 | 45 | 22.22 |
| 2022-06-30 | $322k | 30k | 10.87 |
| 2022-03-31 | $68k | 4.7k | 14.34 |
| 2021-12-31 | $163k | 8.2k | 19.78 |
| 2021-09-30 | $2.0k | 74 | 27.03 |